Financhill
Sell
45

STOK Quote, Financials, Valuation and Earnings

Last price:
$8.61
Seasonality move :
19.76%
Day range:
$8.18 - $8.72
52-week range:
$5.60 - $17.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
26.11x
P/B ratio:
1.96x
Volume:
876.9K
Avg. volume:
778.7K
1-year change:
32.72%
Market cap:
$455.5M
Revenue:
$8.8M
EPS (TTM):
-$2.10

Earnings Data

Next earnings date for STOK
Mar 25
2025
Most recent earnings per share
-$0.47
Beat by $0.07
(Nov 5/2024)
Consensus Estimate
-$0.54
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STOK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $7.3M -- -- -$0.52 --
03/25/2025 Q4 $4.3M -- -- -$0.53 --
11/05/2024 Q3 $3.6M $4.9M -$0.47 -$0.54 $0.07
08/07/2024 Q2 $3.3M $4.8M -$0.46 -$0.56 $0.10
05/06/2024 Q1 $3.2M $4.2M -$0.57 -$0.61 $0.04
03/25/2024 Q4 $3.2M $2.8M -$0.60 -$0.63 $0.03
11/07/2023 Q3 -- -- -$0.55 -$0.65 $0.10
08/07/2023 Q2 -- -- -$0.69 -$0.66 -$0.03
05/04/2023 Q1 -- -- -$0.53 -$0.72 $0.19
03/10/2023 Q4 -- -- -$0.65 -$0.71 $0.06
11/14/2022 Q3 -- -- -$0.66 -$0.68 $0.02
08/08/2022 Q2 -- -- -$0.63 -$0.69 $0.06
05/10/2022 Q1 -- -- -$0.66 $0.13 -$0.79
03/10/2022 Q4 -- -- -$0.66 -$0.61 -$0.05
11/08/2021 Q3 -- -- -$0.61 -$0.55 -$0.06
08/10/2021 Q2 -- -- -$0.60 -$0.46 -$0.14
05/10/2021 Q1 -- -- -$0.46 -$0.44 -$0.02
03/09/2021 Q4 -- -- -$0.42 -$0.42 $0.00
11/12/2020 Q3 -- -- -$0.41 -$0.43 $0.02
08/10/2020 Q2 -- -- -$0.39 -$0.36 -$0.03
05/15/2020 Q1 -- -- -$0.34 -$0.37 $0.03
03/23/2020 Q4 -- -- -$0.31 -$0.30 -$0.01
11/12/2019 Q3 -- -- -$0.26 -$0.28 $0.02
08/14/2019 Q2 -- -- -$1.54 -$1.63 $0.09

Stoke Therapeutics Earnings Questions

  • How Much did Stoke Therapeutics Generate in Revenue Last Quarter?

    Stoke Therapeutics reported $4.9M worth of top line sales in its most recent quarter.

  • Did Stoke Therapeutics Beat Earnings Last Quarter?

    Stoke Therapeutics announced earnings per share of -$0.47 which represents a beat of analyst forecast a -$0.54 per share.

  • Is Stoke Therapeutics Profitable?

    Stoke Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Stoke Therapeutics EPS Next Year?

    Stoke Therapeutics's earnings are forecast to decrease from -$2.38 per share to -$2.11 per share next year representing a decrease of -11.3%.

  • When is Stoke Therapeutics's Earnings Date?

    Stoke Therapeutics's next earnings date is March 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock